Lipigon Pharmaceuticals
0.116
SEK
-1.53 %
Less than 1K followers
LPGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-1.53%
+5.08%
+0.35%
+0.35%
-54.32%
-67.92%
-96.57%
-
-98.43%
Lipigon Pharmaceuticals operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and includes drugs for rare diseases. These are mainly treatments for diseases caused by disorders in the body's handling of fats. In addition to the main business, service and associated ancillary services are also offered. Lipigon Pharmaceuticals operates worldwide, with the largest presence in the Nordic market.
Read moreMarket cap
17.18M SEK
Turnover
61.02K SEK
Revenue
10.29M
EBIT %
-248.62 %
P/E
-
Dividend yield-%
-
Financial calendar
28/4
2025
Extraordinary general meeting '25
22/5
2025
General meeting '25
27/5
2025
Interim report Q1'25
All
Webcasts
Press releases
3rd party
ShowingAll content types
Redeye: Lipigon Q4 2024 - Rights issue funds 2025
Lipigon publicerar bokslutskommunikén för januari - december 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools